Nokia Corporation (ADR) (NYSE:NOK) will release its next earnings report, and Bernstein analysts think the company could disappoint on earnings but beat on revenue estimates. However, they think the company’s stock could pull back, not only because of disappointing earnings, but also other news. Nokia Corporation (ADR) (NYSE:NOK) shares after opening at $7.21 moved to $7.22 on last trade day and at the end of the day closed at $7.03. Company price to sales ratio in past twelve months was calculated as 1.50 and price to cash ratio as 2.06. Nokia Corporation (ADR) (NYSE:NOK) showed a negative weekly performance of -5.38%.
The day-long conference, called Facebook F8, will bring developers and leaders from the tech world together on Wednesday in San Francisco. Facebook Inc. (NASDAQ:FB) founder and CEO Mark Zuckerberg will give the keynote and then top-level employees from the social network as well as Instagram and Parse will offer break-out sessions on different subjects, like monetization and building apps. Facebook Inc. (NASDAQ:FB) shares fell -2.72% in last trading session and ended the day on $56.14. FB return on equity ratio is recorded as 13.30% and its return on assets is 11.30%. Facebook Inc. (NASDAQ:FB) yearly performance is 109.09%.
Zynga Inc. (NASDAQ:ZNGA) tanked on NASDAQ after producing an earnings report that was about on par with what analysts had expected. Zynga reported bookings of $168 million and adjusted EBITDA of $14 million, with a non-GAAP earnings loss per share of $0.01. Analysts were expecting the single cent loss, but had forecasted revenue of $164 million. However, the revenue is a 36% drop as compared to the company’s first quarter revenue last year. Not to mention that the company had conjured up a $4 million profit in the first quarter of 2013. Zynga Inc. (NASDAQ:ZNGA) shares moved down -4.41% in last trading session and was closed at $3.90, while trading in range of $3.76 – $4.11. Zynga Inc. (NASDAQ:ZNGA) year to date (YTD) performance is 2.63%.
Pfizer Inc. (NYSE:PFE) Confirms Renewed Attempt To Acquire AstraZeneca. Pfizer Inc. revealed that it was looking to acquire British pharmaceutical company, AstraZeneca, for $100 billion. Pfizer Inc. (NYSE:PFE) weekly performance is 3.82%. On last trading day company shares ended up $32.04. Pfizer Inc. (NYSE:PFE) distance from 50-day simple moving average (SMA50) is 1.44%. Analysts mean target price for the company is $34.09.
Leave a Reply